Posts Tagged ‘pharmaceutical industry’

Renowned researcher says public is mislead about antidepressants: they simply put people into drug induced states

Monday, November 23rd, 2009

David Gutierrez
NaturalNews.com
November 23, 2009

Contrary to the impression promoted by the psychiatric and drug industries, psychiatric drugs do not work by correcting a chemical imbalance in the brain, Joanna Moncrieff of University College London wrote recently in an opinion piece for the BBC. Instead, such drugs merely put people into “drug-induced states” that make it harder for them to experience the symptoms of their illness.

“Magazines, newspapers, patients’ organizations and Internet sites have all publicized the idea that conditions like depression, anxiety, schizophrenia and bipolar disorder can be treated by drugs that help to rectify an underlying brain problem … just like a diabetic needs to take insulin,” Moncrieff writes. “The trouble is, there is little justification for this view.”

Moncrieff notes that prior to the 1950s, mental health workers largely saw antidepressants as psychoactive drugs, primarily sedatives, that eased the symptoms of depression without addressing the underlying cause – much as over-the-counter cold drugs may stop a runny nose without affecting the cold virus. This view was eventually replaced by the idea that depression, schizophrenia, anxiety and other mental health conditions result from chemical imbalances in the brain, imbalances that can be corrected by the right “magic bullet.”

Read entire article: http://www.naturalnews.com/027555_antidepressants_chemical_imbalances.html

« Return to news items


Share

U.S. Sen Grassley-Demanding transparency for Pharma funds paid to doctors, researchers, patient ‘advocacy’ groups

Thursday, November 19th, 2009

IowaPolitics.com
November 19, 2009

WASHINGTON — Senator Chuck Grassley has asked leading medical schools to describe their policies on ghostwriting as part of his continuing effort to shed light on financial ties between the pharmaceutical industry and medical professionals.

“I’m interested in transparency, and academic institutions play an important role in establishing adequate and meaningful disclosure. Letting the sun shine in and making information public is basic to building people’s confidence in medical research and the practice of medicine,” Grassley said.

Last July, Grassley wrote to eight leading medical journals to ask the same kinds of questions he’s presented to the medical schools. Prior to that, he asked two major drug companies about allegations that they hired ghostwriters to draft articles promoting company products and seek academics to sign on as primary authors.

Grassley also has conducted oversight and sought disclosure with physicians, continuing medical education and the patient advocacy community. He has worked to expose cases where there was vast disparity between drug-company payments received and reported by leading medical researchers. The National Institutes of Health is working on new disclosure guidelines for federal grant recipients in response to Grassley’s work.

In January, Grassley and Senator Herb Kohl introduced, for the second time, the Physician Payments Sunshine Act. The legislation would require annual public reporting by drug, device and biologic manufacturers of payments made to physicians nationwide. It was included in the health care reform bill passed in October by the Senate Committee on Finance.

Read entire article: http://www.iowapolitics.com/index.iml?Article=177376

« Return to news items


Share

70% of psychiatrists in charge of adding new mental disorders to psych billing bible (DSM) have conflicts/ties to Pharma

Wednesday, November 18th, 2009

Roger Collier
Canadian Medical Association Journal
November 17, 2009

Former editors of the Diagnostic and Statistical Manual of Mental Disorders (DSM) have publicly declared their concerns that the ongoing revision process of the influential publication has been cloaked in secrecy. In recent months, debate about the confidentiality agreement that contributors must now sign has been playing out in the pages of the Psychiatric Times. Dr. Allen Frances, editor of DSM-IV, has written several editorials slamming the DSM-V task force for their lack of transparency.

The “real problem now is the almost complete lack of openness about [DSM-V] methods, progress, timelines, and products,” Frances writes in an email.

Dr. Robert Spitzer, editor of DSM-III, has expressed a similar opinion. In 2008, he wrote an open letter criticizing the confidentiality agreement (Psychiatr News 2008; 43:26). In the letter, Spitzer says that he requested the minutes of a DSM-V meeting but was refused. The confidentiality mandate, he wrote, would prohibit the free exchange of information between the DSM task force and outside experts that is essential to effectively revising the manual.

Read entire article: http://www.cmaj.ca/earlyreleases/17nov09-dsm-revision-surrounded-by-controversy.shtml

« Return to news items


Share

“Was Fort Hood Killer On Psychotropic Drugs?” – Media fails to ask if Hasan was on SSRI’s

Friday, November 6th, 2009

Paul Joseph Watson
Alex Jones’ Prison Planet.com
November 6, 2009

Despite the fact that Fort Hood gunman Nidal Malik Hasan was a psychiatrist, the media has failed to even raise the question of whether he was taking psychotropic drugs before he gunned down over a dozen of his colleagues during yesterday’s tragic rampage, a hefty indictment of how the establishment rushes to blame politics, religion, gun rights, or any other factor for mass shootings in order to hide the direct link between such massacres and the use of anti-depressant drugs.

It has been confirmed that Hasan was an Army psychiatrist at Fort Hood. Psychiatrists have a history of “self-medication” because of the easy access they have to psychotropic drugs.

In almost every major mass shooting over the past two decades, since anti-depressant drugs became popular, the killer has been on SSRI’s – serotonin reuptake inhibitors.

The establishment media, allied closely as it is with the pharmaceutical industry, uniformly fails to stress this common factor, preferring instead to blame shootings on gun rights or, as in the case of Hasan, political motives.

Read entire article: http://www.prisonplanet.com/was-fort-hood-killer-on-psychotropic-drugs.html

« Return to news items


Share

Dr. Peter Breggin: Antipsychotic Drugs, Their Harmful Effects, and the Limits of Tort Reform

Monday, November 2nd, 2009

Dr. Peter Breggin
The Huffington Post
October 31, 2009

There are many problems within our legal system that could benefit from reform. But within the area in which I have great experience as a psychiatric expert, so-called tort reform has already gone too far. It is already too difficult for injured patients or their surviving families to bring malpractice suits against physicians and health facilities, and product liability suits against drug companies, even when their cases have great merit. I believe in private health care and I believe in the free market, but liberty requires checks and balances. The right to sue medical practitioners and pharmaceutical companies provides a necessary control in our free market system, as well as a means for individuals to seek compensation and justice.

Harm Caused by Antipsychotic Drugs

For illustrative purposes, I’ll focus on the newer antipsychotic drugs, the so-called atypicals, including Zyprexa, Risperdal, Geodon, Seroquel, and Abilify. These drugs produce horrendous adverse effects that often lead the victims or their surviving families to consider bringing lawsuits against doctors, health care facilities, or drug companies.

First, the antipsychotic drugs produce tardive dyskinesia. Tardive dyskinesia involves drug-induced abnormal movements that commonly disfigure patients and in some cases result in lifelong pain and total disability.

Read entire article: http://www.huffingtonpost.com/dr-peter-breggin/antipsychotic-drugs-their_b_341108.html

« Return to news items


Share

Irish Times: “Tinseltown gets the big picture on psychiatry – it sucks”

Sunday, October 25th, 2009

Irish Times.com
October 24, 2009

LOS ANGELES LETTER: “PSYCHIATRY: AN Industry of Death” is the name of a museum on Sunset Boulevard. For several hours you can roam a dungeon-style premises that delivers a clear and sustained message: psychiatry sucks, writes JOHN FLEMING.

As the LA palm trees outside overstretch themselves into the blue sky and six lanes of flash cars and pick-up trucks roar past, you are sealed into a theatrical world of condemnation.

In a stage set of straitjackets, restraining tables and human cattle-prods, a versioned world of psychiatry’s lobotomies, ECT and involuntary commitments is vividly dramatised.

Fourteen of Hollywood’s most secret short films and hundreds of dark exhibits sketch a shameful history of the profession, blaming it for racism, the Holocaust, botched psychosurgery and a world dependent on the pharmaceutical industry.

Read entire article: http://www.irishtimes.com/newspaper/world/2009/1024/1224257390508.html

« Return to news items


Share

Sen. Grassley’s bill requires disclosure of Pharma $ to doctors, ghost writers & “patient advocacy” groups like NAMI

Friday, October 23rd, 2009

IowaPolitics.com
October 23, 2009

WASHINGTON — Senator Chuck Grassley is continuing his campaign to establish transparency with the financial relationships between drug companies and medical professionals.

Grassley has conducted oversight and sought disclosure with physicians, especially those involved in influential taxpayer-sponsored medical research; medical journals containing ghostwritten articles; medical colleges; continuing medical education; and the patient advocacy community.

This week, the senator released a letter seeking information from state-level chapters of the National Alliance on Mental Illness. The inquiry follows one Grassley made earlier this year asking NAMI and other patient advocacy groups and medical professional societies for information about financial relationships with drug companies and medical device manufacturers. The letter is posted with this news release at http://grassley.senate.gov and http://finance.senate.gov.

“Public trust and public dollars are at stake,” Grassley said. “People rely on medical advice and taxpayers spend billions of dollars on prescription drugs and devices through Medicare and Medicaid. Public confidence could be greatly improved if financial relationships were disclosed. My legislative effort is a common-sense reform that would require the pharmaceutical and device industry to report the money it gives to doctors.”

Read entire article: http://www.iowapolitics.com/index.iml?Article=174518

« Return to news items


Share

Florida drugging of Foster Care Children & resultant death of 7-year-old finally prompts state action

Sunday, October 11th, 2009

Fred Grimm
Miami Herald
October 10, 2009

Gabriel Myers finally matters.

Too late for him — the foster kid we addled with anti-depressants and anti-psychotics without quite knowing the effects drug cocktails might have on a 7-year-old.

One potential side effect of feeding Lexapro, Zyprexa and Symbyax to a 67-pound child became grotesquely obvious. Young Gabriel coiled a shower hose around his neck and hanged himself in the bathroom of his Miramar foster home.

Gabriel’s death on April 15 roiled child advocates, critics of the pharmaceutical industry, the media. But this week, a child’s suicide finally elicited a reaction where it matters.

“I tell you, we’re going to do something. We’re going to do a full-court press,” said State Sen. Tony Hill, a Jacksonville Democrat, still shocked after members of the Senate Children, Families and Elder Affairs Committee were briefed Wednesday by the Gabriel Myers Task Force.

Read entire article: http://www.miamiherald.com/431/story/1277059.html

« Return to news items


Share

Behind the Marketing of antidepressants: Psychiatrists get more Pharma $$ than any other medical specialty

Tuesday, September 1st, 2009

Gardiner Harris
The New York Times
September 1, 2009

The pharmaceutical industry has developed thousands of medicines that have saved millions of lives, but it has also used its marketing muscle to successfully peddle expensive pills that are no more effective than older drugs sold at a fraction of the cost.

No drug better demonstrates the industry’s salesmanship than Lexapro, an antidepressant sold by Forest Laboratories. And a document quietly made public recently by the Senate’s Special Committee on Aging demonstrates just how Forest managed to turn a medicinal afterthought into a best seller.

The document, “Lexapro Fiscal 2004 Marketing Plan,” is an outline of the many steps Forest used to make Lexapro a success. Because of concerns from Forest, the Senate committee released only 88 pages of the document, which may have originally run longer than 270 pages. “Confidential” is stamped on every page.

But those 88 pages make clear that one of the principal means by which Forest hoped to persuade psychiatrists, primary care doctors and other medical specialists to prescribe Lexapro was by finding many ways to put money into doctors’ pockets and food into their mouths.

Read entire article: http://www.nytimes.com/2009/09/02/business/02drug.html

« Return to news items


Share

Teen Screen, Cynical Deception, Dangerous Illusion

Wednesday, August 26th, 2009

By Allen Jones, Former Investigator, Pennsylvania Office of the Inspector General
August 26, 2009

As human beings we have a strong natural impulse to protect our kids from harm.  As a society we create norms, laws and institutions to protect, educate and nurture our young.  Consciously and instinctively we safeguard our children.

Teen Screen is a bitter and cynical betrayal of this noble human impulse. Promoted as an aid to preventing suicide and identifying so-called mental disorders, Teen Screen is in fact a nefarious effort to recruit our children into the quagmire of biological psychiatry.

I believe the majority of parents who support Teen Screen are well meaning and genuinely have the best interests of children at heart.  I believe they have been duped and beguiled by slick marketing that appealed to their better instincts while simultaneously defeating those instincts.

Teen Screen was developed and promoted by persons with deep financial ties to makers of psychiatric drugs.  These drug companies have a profit-driven incentive to maximize the use of their drugs.  Teen Screen furthers this corporate goal by following a psychiatric model intended to translate normal human experience into symptoms of mental illness.

Teen Screen’s centerpiece is a survey which claims to identify signs of mental illness and suicidality in children and adolescents.  How does it do this?  Teen Screen identifies feelings and emotions experienced by children and adolescents. It then translates these feelings and emotions into “symptoms” of mental illness. In this way, Teen Screen is in lock-step with modern psychiatry.

The field of psychiatry has attached clinical pathology to the presence or absence of literally every mood or feeling in the normal range of human emotions. The diagnostic criteria outlined in psychiatry’s Diagnostic and Statistical Manual of Mental Disorders (DSM) essentially identify the presence or absence of feelings and subjectively determine if these feelings are “normal” or “abnormal.”  If the feeling or emotion is considered inappropriate in intensity or context, that feeling becomes a “symptom” of “mental illness,” treatable by medication.  After all, psychiatric drugs are designed to treat “symptoms” not cure illness.

Any child who lives life fully and freely will experience a full range of human emotions.  They will experience sadness, gladness, apathy, energy, optimism, pessimism, fear, fearlessness, love, hate, suspicion, trust and myriad other feelings.  Experiencing these feelings and learning to be guided appropriately by them is a vital part of growth and maturation.  Teen Screen identifies these feelings, subtlety manipulates or ignores context and labels the feelings as possible “symptoms” of mental illness.

Imagine the emotional states experienced by a child before, during and after a major life event such as playing in the “Big Game” with an archrival school.  The child might be distracted by excited anticipation for days before the event.  He might have difficulty sleeping the night before the game.  He might be unable to think of anything else on game day, even during classes.  He will likely be very highly energized during the event.  Depending on the game outcome, the child might be elated or saddened for days afterwards.

Now imagine the child later being asked questions such as these:

Have you ever felt so full of energy that it was difficult to sit still?

Have you ever felt anxious when you had to say or do something in front of people?

Have you ever been so concerned about something that you could not sleep?

Have you ever felt so happy that you could not concentrate?

Have you ever felt so sad that you could not focus on your school work?

The participant in the big game and the spectators of the big game might answer “yes” to most or all of the above questions.  Following the creed of modern psychiatry, Teen Screen would determine the child to be at risk of mania, social anxiety disorder, depression and possibly bipolar disorder.  The child would be flagged for further psychiatric evaluation.

The above scenario is not far-fetched. Things like this are happening every day. Teen Screen has been proven to have “false positive” rates as high as 84%.

Teen Screen is a device to distill “symptoms” from normal life experience and generate unlimited referrals to mental health professionals whose primary method of treatment involves drugging.  Please do not be duped by this ferocious, Pharma-friendly wolf in sheep’s clothing.

Allen Jones, worked as an investigator in the Pennsylvania Office of the Inspector General (OIG), and gained widespread national and international attention as a whistleblower after uncovering pharmaceutical industry payments to government officials for the purpose of implementing a national mental health screening/psychotropic drug treatment plan based on the controversial Texas Medication Algorithm Project (TMAP). In May, 2004 the British Medical Journal reported Jones had uncovered evidence major drug companies sought to influence government officials and that Jones was escorted out of his workplace on April 28, 2004, after OIG officials accused him of talking to the press. Jones chose to disclose his findings to the press precisely because of corrupt behavior by OIG officials themselves, alleging the OIG’s policy was “unconstitutional.”

RETURN TO BLOGS PAGE


Share